Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-15-039407
Filing Date
2015-06-26
Accepted
2015-06-26 16:35:16
Documents
1
Period of Report
2015-06-24

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v414107_4.html 4  
1 OWNERSHIP DOCUMENT v414107_4.xml 4 3831
  Complete submission text file 0001144204-15-039407.txt   5322
Mailing Address C/O GENOCEA BIOSCIENCES, INC. 100 ACORN PARK DRIVE, 5TH FLOOR CAMBRIDGE MA 02140
Business Address
Higgins Michael J (Reporting) CIK: 0001478521 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36199 | Film No.: 15955554

Mailing Address 99 HAYDEN AVENUE SUITE 390 LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE SUITE 390 LEXINGTON MA 02421 (781) 357-2333
Pulmatrix, Inc. (Issuer) CIK: 0001574235 (see all company filings)

EIN.: 461821392 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations